• Dev Priya Institute of Medical Sciences, Banaras Hindu University, Varanasi
  • Purohit S. Banaras Hindu University
  • Pandey B. L. Banaras Hindu University


Reimbursement, Antihypertensive, Pharmacoeconomics, Prescription


Objective: Pharmacoeconomics evaluates the relationship between clinical, economic, and humanistic outcome for maximizing the value for each monetary unit spent on product and services. So the objective of the study was to provide the option of pharmacoeconomic medications to the hypertensive patients thus saving the cost to the university as well as to its staff of lower economic strata.

Methods: The prescriptions are generated at University Health Center along at the tertiary care center i.e. University hospital. Most often patients are prescribed medications of specific brands by the University hospital consultants, which are not available in the health center. The expenditure for self procured medication is subject to reimbursement by the University.

The personal characteristics of patients like age, sex, department of treatment, diagnosis, duration of therapy, change in therapy etc. were noted. The exact formulation and manufacturer's details were recorded. Retail cost of a particular drug available from different manufacturers in the same dose form, strength and quantity were also recorded wherever found appropriate.

Results: Majority of patients were old and evenly bearing co-morbidity with hypertension. Judicious choice of common medicines may maximize the economical use of Institutional financial resources for the healthcare and economical expenditure for the patients as well without compromising the treatment of the disease thus fulfilling the objective.

Conclusion: The therapy of hypertension with economical antihypertensive drugs or generic drugs may provide an economical option for the common people and reduced expenditure for the University.



Download data is not yet available.

Author Biography

Dev Priya, Institute of Medical Sciences, Banaras Hindu University, Varanasi

Department of Pharmacology,


Hazlet T., Hu T. Association between formulary strategies and hospital drug expenditures. Am. J. Hosp. Pharm. 1992;49:2207–10.

Lawes CM, Van der Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1:estimates of blood pressure levels. J Hypertens 2006;24(3):413-22.

Kearney PM, Whelton M, Reyonolds K, Muntner P, Whelton PK, He J. Global burden of Hypertension: analysis of worldwide data; Lancet 2005;365:217-23.

Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043–50.

Chobanian AV, Bakris GL, Black HR et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA 2003;289:2560–72.

Strube G. Prescribing within a budget. Practitioner. 1993;237:73-75.

Hansson L. The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension. J Hypertens 1996;14:537-44.

Fretheim A and Oxman AD. International variation in prescribing antihypertensive drugs: Its extent and possible explanations. BMC Health Services Research 2005, 5:21.

Cunningham G, Dodd TR, Grant DJ, Murdo ME, Richards RM. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age & Ageing. 1997;26:375–82.

Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005;31:4-11.

Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997;157:2089-2096.

Oslo, Norway, 2003:World Health Organization; 2003;Introduction to drug utilization researchâ€. ISBN 82-8082-039-6.

Chaturvedi M, Jindal S, Kumar R. Lifestyle modification in hypertension in the Indian context. J Indian Acad Commun Med. 2009;10:46–51.

Lee PKF, Li RKL, Chen JCN, Chang S, Lee SC, Tomlinson B. A prescription survey in a hospital hypertension out-patient clinic. Br J Clin Pharmacol. 1997;44:577-82.

Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997;277:739–45.

Pai PG, Shenoy J, Sanji N. Prescribing patterns of antihypertensive drugs in a South Indian tertiary care hospital. Drug Invention Today 2011;3:38-40.

Sandozi T, Emani VK. Survey of prescription pattern of anti-hypertensive drugs in hypertensives and hypertension associated diabetics. Int J Pharm Biol Sci 2010;1:23-6.

Abidi A, Gupta S, Kansal S. Prescription auditing and drug utilization pattern in a tertiary care teaching hospital of western UP. Int J Basic Clin Pharmacol 2012;1(3):184-90.

Isah AO, Laing R, Quick J, Mabadeje AFB, Santoso B, Hogerzeil H, et al. The Development of reference values for the world health organization (WHO) health facility core prescribing indicators. West Afr J Pharmacol Drug Res 2002;18(1-2):6–11.

Jhaveri BN, Patel TK, Barvaliya MJ, Tripathi CB. Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India. J Pharmacol Pharmacother 2014;5(1):15-20



How to Cite

Priya, D., P. S., and P. B. L. “DRUG UTILIZATION STUDY AND EVALUATION OF ANTI-HYPERTENSIVE PRESCRIPTIONS FROM MEDICAL REIMBURSEMENT APPLICATIONS AT UNIVERSITY HEALTH CARE FACILITY, BHU, VARANASI”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 6, June 2015, pp. 283-6, https://journals.innovareacademics.in/index.php/ijpps/article/view/4508.



Original Article(s)